黄色小说视频-日本少妇高潮抽搐-国内自拍av-天堂中文资源在线-蜜桃视频在线入口www-91久久综合-亚洲视频在线一区-日日夜夜拍-国产精品资源在线观看-欧美激情国产精品免费-人妻少妇久久中文字幕-成人免费无码大片a毛片-香蕉污视频在线观看-日本电影成人-国内精品久久99人妻无码

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > HEY-T30
最近瀏覽歷史
聯系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮海區莊市街道興莊路9號
  • 創e慧谷42號樓B幢401室
HEY-T30
HEY-T30
規格:
貨期:
編號:B197879
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規格:
凍干粉
斜面
甘油
平板


產品名稱 HEY-T30
商品貨號 B197879
Organism Homo sapiens, human
Tissue ovary
Cell Type ovarian carcinoma
Product Format frozen
Morphology epithelial-like
Culture Properties adherent
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease papillary cystadenocarcinoma of the ovary
Gender female
Applications This cell line can be used to study resistance to microtubule stabilizing agents and other chemotherapy resistance mechanisms.
Storage Conditions liquid nitrogen vapor phase
Images Cell Micrograph of ATCC CRL-3252
Derivation The parental cell line, HEY, was derived from a human ovarian cancer xenograft originally grown from a peritoneal sample from a patient with moderately differentiated papillary cystadenocarcinoma of the ovary. CRL-3252, HEY-T30, is a derivative of the HEY cell line and is resistant to Taxol.  It was developed by exposure of its parental cell line, HEY, to stepwise escalating concentrations of Taxol over a 6-month period and it is maintained in medium containing 30 nmol/L Taxol.
Receptor Expression

Insulin-like growth factor 2 (IGF2; documented in PubMed 20404007)

Complete Growth Medium The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium:
  • 30 nM Paclitaxel
  • fetal bovine serum to a final concentration of 10%

Subculturing Note: Add Taxol to FBS-containing RPMI-1640 medium each time cells are fluid changed or manipulated. 

Volumes used in this subculture protocol are for a 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.

  1. Remove and discard culture medium.
  2. Briefly rinse the cell layer with 1.0 to 2.0 mL Ca++/Mg++ free Dulbecco's phosphate-buffered saline (D-PBS) (ATCC® No. 30-2020) or 0.25% (w/v) Trypsin - 0.53 mM EDTA (ATCC® No. 30-2101) solution to remove all traces of serum which contains trypsin inhibitor.
  3. Add 1.0 to 2.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). 
    Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
  4. Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting.
  5. Transfer cell suspension to a centrifuge tube and spin at approximately 125 x g for 5 to 10 minutes. Discard supernatant.
  6. Resuspend the cell pellet in 10mL fresh growth medium. 
  7. Add appropriate aliquots of the cell suspension to new culture vessels.
  8. Incubate cultures at 37°C.

Subcultivation ratio: A subcultivation ratio of 1:3 to 1:12 is recommended.
Medium renewal: 2 to 3 times weekly
Culture Conditions Temperature: 37°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
STR Profile Amelogenin: X
CSF1PO: 10,11
D13S317: 11
D16S539: 8,12
D5S818: 11,12
D7S820: 12
THO1: 8,9.3
TPOX: 11
vWA: 16,17
Population Doubling Time 18-22 hours (in e-mail from Dr. Brouwer dated 12/02/14)
Name of Depositor Jurriaan Brouwer-Visser Institution: Albert Einstein College of Medicine, Bronx, NY
Year of Origin 2006
References

Buick RN, et al. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res. 45: 3668-3676, 1985. PubMed: 4016745

Huang GS, et al. Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer. Clin. Cancer Res. 16(11): 2999–3010, 2010. PubMed: 20404007

King ER, et al. The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma. Gynecol. Oncol. 123(1): 13-18, 2011. PubMed: 21726895

梅經理 17280875617 1438578920
胡經理 13345964880 2438244627
周經理 17757487661 1296385441
于經理 18067160830 2088210172
沈經理 19548299266 2662369050
李經理 13626845108 972239479